Clinical Trial

A Study Comparing Doxycycline and Levofloxacin for Treating COPD Exacerbations

Study acronym: DOLE-COPD
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 8, 2025 (before its estimated July 28, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study will include patients with chronic obstructive pulmonary disease (COPD) who present with an acute exacerbation. Participants will be randomly assigned to receive either doxycycline or levofloxacin for 5 days. The aim is to compare how effective each antibiotic is in improving symptoms after 2 days of treatment.
Trial Details
NCT Number NCT06915688
Lead Sponsor Amina Aslam
Conditions COPD
Enrollment 188 participants
Start Date 2025-04-15
Primary Completion 2025-07-28 (estimated)
Study Completion 2025-07-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-08